Sham-controlled RCT in 109 patients with faecal incontinence: translumbosacral neuromodulation with 2400 or 3600 magnetic stimulations gave a ≥50% fall in weekly episodes in 65.8% and 81.1% vs 32.4% with sham. No treatment-related serious adverse events.
RCTn = 109 patients
Rao et al. Randomized Sham-Controlled Trial of Translumbosacral Neuromodulation Therapy for Fecal Incontinence